(Press-News.org) A newly discovered molecule provides a new drug target for controlling both asthma-induced muscle thickening and cancerous tumor growth. This molecule, called "microRNA-10a," normally helps genes produce proteins or make copies of themselves, also play an important role in the growth or overgrowth of human airway smooth muscle cells and some forms of cancer. This newly discovered role, which was published in the May 2014 issue of The FASEB Journal, suggests that manipulating microRNA-10a could lead to new asthma and cancer drugs.
"We hope this study will serve as the fundamental building block for future follow-up studies on evaluating microRNA-10a's potential in treating asthma and uncontrolled tumor growth," said Quan Lu, Ph.D., a researcher involved in the work from the Program in Molecular and Integrative Physiological Sciences at the Harvard School of Public Health in Boston, MA.
Lu and colleagues made their discovery by using state-of-the-art sequencing to identify microRNA-10a as the most highly enriched microRNA molecule in the human airway smooth muscle cells. To study the function of this microRNA, researchers then used an unbiased genomic approach (microarray gene profiling) to compare the differences between cells treated with microRNA-10a and not treated (control). They found that microRNA-10a regulates pathways that control cell proliferation. To further uncover the mechanistic link of microRNA-10a and smooth muscle cell proliferation, a series of biochemical tests were conducted and demonstrated that microRNA-10a inhibits the PI3 kinase, a master regulator of cell proliferation. This strongly suggests that microRNA-10a could become a novel asthma drug target to treat airway hypertrophy, and that microRNA-10a may be a therapeutic target to treat cancer tumor growth.
"Asthma and cancer may seem to be unrelated, but this report shows that both diseases may share a common molecular link," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "With potential applications in asthma and cancer treatment, hopefully future research into this regulatory molecule can be accelerated."
INFORMATION:
Receive monthly highlights from The FASEB Journal by e-mail. Sign up at http://www.faseb.org/fjupdate.aspx. The FASEB Journal is published by the Federation of the American Societies for Experimental Biology (FASEB). It is among the most cited biology journals worldwide according to the Institute for Scientific Information and has been recognized by the Special Libraries Association as one of the top 100 most influential biomedical journals of the past century.
FASEB is composed of 26 societies with more than 115,000 members, making it the largest coalition of biomedical research associations in the United States. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.
Details: Ruoxi Hu, Wenchi Pan, Alexey V. Fedulov, William Jester, Matthew R. Jones, Scott T. Weiss, Reynold A. Panettieri, Jr., Kelan Tantisira, and Quan Lu. MicroRNA-10a controls airway smooth muscle cell proliferation via direct targeting of the PI3 kinase pathway
FASEB J May 2014 28:2347-2357; doi:10.1096/fj.13-247247 ; http://www.fasebj.org/content/28/5/2347.abstract
New discovery: Molecule links asthma and cancer and could aid in developing new treatments
New research in The FASEB Journal suggests that microRNA-10a is highly expressed in human airway smooth muscle cells and controls their growth; it also inhibits PI3, a master regulator of cell proliferation
2014-05-01
ELSE PRESS RELEASES FROM THIS DATE:
Killing Kindlin-3 to cure breast cancer: 'Blood' protein implicated
2014-05-01
A protein believed to be limited to the hematopoietic system, called Kindlin-3, has been identified as a major player in both the formation and spread of breast cancer to other organs. This discovery, published in the May 2014 issue of The FASEB Journal, could open the door to an entirely new class of breast cancer drugs that targets this protein's newly found activity.
"Kill Kindlin-3 to cure cancer," said Elzbieta Pluskota, Ph.D., a researcher involved in the work from the Department of Molecular Cardiology at the Cleveland Clinic Lerner Research Institute in Cleveland, ...
Monitoring, management, and oversight critical for responsible shale gas development
2014-05-01
Ottawa (May 1st, 2014) – A new expert panel report, Environmental Impacts of Shale Gas Extraction in Canada, concludes that shale gas development must be supported by well-targeted science and management strategies to understand and mitigate potential impacts. The report, released today by the Council of Canadian Academies, addresses environmental and associated health impacts and offers insights regarding public engagement and trust.
Shale gas is leading an energy boom which is having profound economic, environmental, and social impacts across much of North America. ...
Rules of thumb: 3 simple ideas for overcoming childhood obesity
2014-05-01
New Orleans, LA – Kristopher Kaliebe, MD, Clinical Assistant Professor of Psychiatry at the LSU Health Sciences Center New Orleans School of Medicine, offers parents and caregivers three simple family-oriented goals to overcome the complex problem of childhood obesity and related mental disorders. They involve limit setting to address the brain's "get more" drive strengthened through habitual over-consumption of temptations including highly caloric processed food, hyper-reality media and electronics, as well as excessive sitting. His 3 "rules" of living promote physical ...
Individual brain activity predicts tendency to succumb to daily temptations
2014-05-01
Activity in areas of the brain related to reward and self-control may offer neural markers that predict whether people are likely to resist or give in to temptations, like food, in daily life, according to research in Psychological Science, a journal of the Association for Psychological Science.
"Most people have difficulty resisting temptation at least occasionally, even if what tempts them differs," say psychological scientists Rich Lopez and Todd Heatherton of Dartmouth College, authors on the study. "The overarching motivation of our work is to understand why some ...
Antimicrobial edible films inhibit pathogens in meat
2014-05-01
Antimicrobial agents incorporated into edible films applied to foods to seal in flavor, freshness and color can improve the microbiological safety of meats, according to researchers in Penn State's College of Agricultural Sciences.
Using films made of pullulan -- an edible, mostly tasteless, transparent polymer produced by the fungus Aureobasidium pulluns -- researchers evaluated the effectiveness of films containing essential oils derived from rosemary, oregano and nanoparticles against foodborne pathogens associated with meat and poultry.
The results demonstrate that ...
Researchers find the accelerator for molecular machines
2014-05-01
How hard can it be to make a wheel rotate in a machine? Very hard actually, when the wheel sits in one of those nano-small molecular machines that are predicted to be running our future machines. But before the molecular machines become part of our daily lives, researchers must be able to control them. A Danish/American research team have now solved part of this problem.
There are large machines and there are small machines - and then there are molecular machines. They are nano-tiny collections of molecular building blocks that together make up a machine and operate various ...
Unlocking a mystery of thalidomide
2014-05-01
In the 1950s and 1960s, pregnant women with morning sickness were often prescribed the new drug thalidomide. Shortly after the medicine was released on the market, a reported 10,000 infants were born with an extreme form of the rare congenital phocomelia syndrome, which caused death in 50 percent of cases and severe physical and mental disabilities in others. Although various factors are now known to cause phocomelia, the prominent roots of the disease can be found in the use of the drug thalidomide.
Now, half a century later, new research by Dr. Noam Shomron, Prof ...
New study suggests combination of statin and omega-3 fatty acid may provide cardioprotective effects
2014-05-01
Boston, MA-- New findings from an in vitro study, led by researchers at Brigham and Women's Hospital (BWH), show that the combination of statins and eicosapentaenoic acid (EPA), an omega-3 fatty acid, may potentially reduce cardiovascular risk. This research is being presented May 1 at a peer-reviewed poster session at the National Lipid Association Scientific Sessions in Orlando, Florida.
"We know that endothelial cell dysfunction is emerging as an early and important predictor of cardiovascular disease and plays an essential role in plaque development. Treatments that ...
Risk of weight gain deters some smokers from seeking treatment to quit
2014-05-01
Smokers may avoid treatment to quit smoking if they previously gained weight while trying to quit, according to researchers at Penn State College of Medicine.
Weight gain is a predictable occurrence for smokers who have recently quit. Within the first year after quitting, they gain an average of eight to14 pounds, and some smokers report that they keep smoking simply because they do not want to gain weight from quitting.
Susan Veldheer, project manager in the Department of Public Health Sciences, predicted that smokers would avoid treatment to quit if they are highly ...
Experimental drug prolongs life span in mice
2014-05-01
CHICAGO --- Northwestern Medicine® scientists have newly identified a protein's key role in cell and physiological aging and have developed – in collaboration with Tohoku University in Japan -- an experimental drug that inhibits the protein's effect and prolonged the lifespan in a mouse model of accelerated aging.
The rapidly aging mice fed the experimental drug lived more than four times longer than a control group, and their lungs and vascular system were protected from accelerated aging, the new study reports.
The experimental drug could potentially be used to treat ...
LAST 30 PRESS RELEASES:
Patrick Tan appointed as Duke-NUS Dean to lead next era of medical innovation and education
Development of a novel modified selective medium cefixime–tellurite-phosphate-xylose-rhamnose MacConkey agar for isolation of Escherichia albertii and its evaluation with food samples
KIST develops full-color-emitting upconversion nanoparticle technology for color displays with ultra-high color reproducibility
Towards a fully automated approach for assessing English proficiency
Increase in alcohol deaths in England an ‘acute crisis’
Government urged to tackle inequality in ‘low-carbon tech’ like solar panels and electric cars
Moffitt-led international study finds new drug delivery system effective against rare eye cancer
Boston stroke neurologist elected new American Academy of Neurology president
Center for Open Science launches collaborative health research replication initiative
Crystal L. Mackall, MD, FAACR, recognized with the 2025 AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology
A novel strategy for detecting trace-level nanoplastics in aquatic environments: Multi-feature machine learning-enhanced SERS quantification leveraging the coffee ring effect
Blending the old and the new: Phase-change perovskite enable traditional VCSEL to achieve low-threshold, tunable single-mode lasers
Enhanced photoacoustic microscopy with physics-embedded degeneration learning
Light boosts exciton transport in organic molecular crystal
On-chip multi-channel near-far field terahertz vortices with parity breaking and active modulation
The generation of avoided-mode-crossing soliton microcombs
Unlocking the vibrant photonic realm: A new horizon for structural colors
Integrated photonic polarizers with 2D reduced graphene oxide
Shouldering the burden of how to treat shoulder pain
Stevens researchers put glycemic response modeling on a data diet
Genotype-to-phenotype map of human pelvis illuminates evolutionary tradeoffs between walking and childbirth
Pleistocene-age Denisovan male identified in Taiwan
KATRIN experiment sets most precise upper limit on neutrino mass: 0.45 eV
How the cerebellum controls tongue movements to grab food
It’s not you—it’s cancer
Drug pollution alters migration behavior in salmon
Scientists decode citrus greening resistance and develop AI-assisted treatment
Venom characteristics of a deadly snake can be predicted from local climate
Brain pathway links inflammation to loss of motivation, energy in advanced cancer
Researchers discover large dormant virus can be reactivated in model green alga
[Press-News.org] New discovery: Molecule links asthma and cancer and could aid in developing new treatmentsNew research in The FASEB Journal suggests that microRNA-10a is highly expressed in human airway smooth muscle cells and controls their growth; it also inhibits PI3, a master regulator of cell proliferation